切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2008, Vol. 02 ›› Issue (01) : 44 -47. doi: 10.3877/cma.j.issn.1674-0807.2008.01.013

综述

CD24 与乳腺癌关系的研究进展
庄建良1,(), 黄荣金1, 许荣誉1, 潘群雄1   
  1. 1.362000 泉州,福建医科大学附属泉州第一医院肿瘤外科
  • 收稿日期:2007-12-05 出版日期:2008-02-01
  • 通信作者: 庄建良
  • 基金资助:
    福建省泉州市科技计划基金(2007Z27)

Advances in research of the relationship between CD24 and breast cancer

Jian-liang ZHUANG(), Rong-jin HUANG, Rong-yi XU, Qunxiong Pan   

  • Received:2007-12-05 Published:2008-02-01
  • Corresponding author: Jian-liang ZHUANG
引用本文:

庄建良, 黄荣金, 许荣誉, 潘群雄. CD24 与乳腺癌关系的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2008, 02(01): 44-47.

Jian-liang ZHUANG, Rong-jin HUANG, Rong-yi XU, Qunxiong Pan. Advances in research of the relationship between CD24 and breast cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2008, 02(01): 44-47.

关键词: CD24, 乳腺癌
[1]
Lu L,Smithson G,Kincade P W, et al.Two models of murine B lymphopoiesis:a correlatio.Eur J Immunol,1998,28:1755-1761.
[2]
Kadmon G,Eckert M,Sammar M,et al. Nectadrin,the heatstable antigen,is a cell adhesion molecule. J Cell Biol,1992,118:1245 -1258.
[3]
Liu Y,Zheng P.CD24:a genetic checkpoint in T-cell homeostasis and autoimmune diseases.Trends Immunol,2007,28:315-320.
[4]
Baumann P,Cremers N,Kroese F,et al.CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis.Cancer Res,2005,65:10 783 -10 793.
[5]
Smith S C,Oxford G,Wu Z,et al. The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer. Cancer Res,2006,66:1917 -1922.
[6]
Kim H J,Kim J B,Lee K M,et al. Isolation of CD24 (high)and CD24 (low/-) cells from MCF-7:CD24 expression is positively related with proliferation,adhesion and invasion in MCF-7.Cancer Lett,2007,258:98 -108.
[7]
Nieoullon V,Belvindrah R,Rougon G,et al. Mouse CD24 is required for homeostatic cell renewal. Cell Tissue Res,2007,329:457 -467.
[8]
Aigner S,Ruppert M,Hubbe M,et al. Heat stable antigen(mouse CD24) supports myeloid cell binding to endothelial and platelet P-selectin.Int Immunol,1995,7:1557 -1565.
[9]
Aigner S,Sthoeger Z M,Fogel M,et al. CD24,a mucin-type glycoprotein,is a ligand for P-selectin on human tumor cells.Blood,1997,89:3385 -3395.
[10]
Friederichs J,Zeller Y,Hafezi Moghadam A,et al.The CD24/P selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells.Cancer Res,2000,60:6714-6722.
[11]
Runz S,Mierke C T,Joumaa S,et al.CD24 induces localization of beta1 integrin to lipid raft domains. Biochem Biophys Res Commun,2008,365:35 -41.
[12]
Schabath H,Runz S,Joumaa S,et al. CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells.J Cell Sci,2006,119:314 -325.
[13]
Kristiansen G, Winzer K J, Mayordomo E, et al. CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res,2003,9:4906 -4913.
[14]
Fogel M,Friederichs J,Zeller Y,et al. CD24 is a marker for human breast carcinoma.Cancer Lett,1999,143:87 -94.
[15]
Bircan S,Kapucuoglu N,Baspinar S,et al. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast:an immunohistochemistry-based pilot study. Pathol Res Pract,2006,202:569 -576.
[16]
Surowiak P,Materna V,Györffy B,et al.Multivariate analysis of oestrogen receptor alpha, PS2, metallothionein and CD24 expression in invasive breast cancers. Br J Cancer,2006,95:339 -346.
[17]
Kordon E C,Smith G H. An entire functional mammary gland may comprise the progeny from a single cell. Development,1998,125:1921 -1930.
[18]
Kalirai H,Clarke R B. Human breast epithelial stem cells and their regulation.J Pathol,2006,208:7 -16.
[19]
Shackleton M,Vaillant F,Simpson K J,et al. Generation of a functional mammary gland from a single stem cell. Nature,2006,439:84 -88.
[20]
Stingl J,Eirew P,Ricketson I,et al. Purification and unique properties of mammary epithelial stem cells.Nature,2006,439:993 -997.
[21]
Cho R W,Wang X,Diehn M,et al. Isolation and Molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors.Stem Cells,2007,Epub ahead of print.
[22]
Al Hajj M,Wicha M S,Benito Hernandez A,et al. Prospective identification of tumorigenic breast cancer cells.Proc Natl Acad Sci USA,2003,100:3983 -3988.
[23]
Yang G P,Ross D T,Kuang W W,et al. Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes.Nucleic Acids Res,1999,27:1517 -1523.
[24]
Sorbello V,Fuso L,Sfiligoi C,et al. Quantitative real-time RTPCR analysis of eight novel estrogen-regulated genes in breast cancer.Int J Biol Markers,2003,18:123 -129.
[25]
Surowiak P,Materna V,Paluchowski P,et al. CD24 expression is specific for tamoxifen-resistant ductal breast cancer cases.Anticancer Res,2006,26:629 -634.
[26]
Sagiv E,Memeo L,Karin A,et al. CD24 is a new oncogene,early at the multistep process of colorectal cancer carcinogenesis.Gastroenterology,2006,131:630 -639.
[27]
Benkerrou M,Jais J P,Leblond V,et al.Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome. Blood,1998,92:3137 -3147.
[1] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[2] 刘伟, 牛云峰, 安杰. LINC01232 通过miR-516a-5p/BCL9 轴促进三阴性乳腺癌的恶性进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 330-338.
[3] 杨柳, 宋振川, 王新乐. 乳腺癌改良根治术联合背阔肌复位的临床疗效评估[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 269-273.
[4] 牛海刚, 郭文科. 三阴性乳腺癌组织中双特异性磷酸酶14与核受体相互作用蛋白1的表达及预后价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(04): 199-205.
[5] 宋佳, 汪波, 孙凯律, 商江峰, 吴旦平, 肇毅. 吲哚菁绿荧光显影联合亚甲蓝染色在乳腺癌前哨淋巴结活检中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 498-501.
[6] 张钊, 骆成玉, 张树琦, 何平, 李旭斌. 不同术式治疗早期乳腺癌的效果及并发症发生率、复发率比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 494-497.
[7] 孙建娜, 孔令军, 任崇禧, 穆坤, 王晓蕊. 266例首诊Ⅳ期乳腺癌手术患者预后分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 502-505.
[8] 唐丹萍, 王萍, 江孟蝶, 杨晓蓉. 自体脂肪移植在乳腺癌术后乳房重建的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 582-585.
[9] 黄程鑫, 陈莉, 刘伊楚, 王水良, 赖晓凤. OPA1 在乳腺癌组织的表达特征及在ER阳性乳腺癌细胞中的生物学功能研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 275-284.
[10] 刘琦, 王守凯, 王帅, 苏雨晴, 马壮, 陈海军, 司丕蕾. 乳腺癌肿瘤内微生物组的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 841-845.
[11] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[12] 王帅, 张志远, 苏雨晴, 李雯雯, 王守凯, 刘琦, 李文涛. 孟德尔随机化及其在乳腺癌研究中的应用进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 671-676.
[13] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[14] 张梦婷, 穷拉姆, 色珍, 李逸群, 德庆旺姆. 西藏地区藏族乳腺癌新辅助化疗的真实世界研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 441-446.
[15] 黄宏山, 陈成彩. 经淋巴管超声造影在乳腺癌前哨淋巴结诊断中的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(04): 411-414.
阅读次数
全文


摘要